Literature DB >> 34050016

Setting ethical limits on human gene editing after the fall of the somatic/germline barrier.

John H Evans1.   

Abstract

The ethical debate about what is now called human gene editing (HGE) has gone on for more than 50 y. For nearly that entire time, there has been consensus that a moral divide exists between somatic and germline HGE. Conceptualizing this divide as a barrier on a slippery slope, in this paper, I first describe the slope, what makes it slippery, and describe strong barriers that arrest the slippage down to the dystopian bottom of pervasive eugenic enhancement. I then show how the somatic/germline barrier in the debate has been weakened to the level of ineffectiveness, with no replacement below. I examine a number of possible barriers on the slope below the somatic/germline barrier, most of which lack sufficient strength. With the exception of the minority of people in the HGE debate who see the eugenic society as utopia, the majority will need a barrier on the slope to stop the slide to dystopia.

Entities:  

Keywords:  bioethics; germline; human gene editing; slippery slope

Year:  2021        PMID: 34050016      PMCID: PMC8179225          DOI: 10.1073/pnas.2004837117

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

Review 1.  Germ-line gene therapy: a new stage of debate.

Authors:  J C Fletcher; W F Anderson
Journal:  Law Med Health Care       Date:  1992 Spring-Summer

2.  Wish-fulfilling medicine in practice: a qualitative study of physician arguments.

Authors:  Eva C A Asscher; Ineke Bolt; Maartje Schermer
Journal:  J Med Ethics       Date:  2012-02-08       Impact factor: 2.903

3.  The World Health Organisation needs to reconsider its definition of health.

Authors:  R Saracci
Journal:  BMJ       Date:  1997-05-10

4.  Brave New Genome.

Authors:  Eric S Lander
Journal:  N Engl J Med       Date:  2015-06-03       Impact factor: 91.245

5.  Can enhancement be distinguished from prevention in genetic medicine?

Authors:  E T Juengst
Journal:  J Med Philos       Date:  1997-04

Review 6.  Geneva Statement on Heritable Human Genome Editing: The Need for Course Correction.

Authors:  Roberto Andorno; Françoise Baylis; Marcy Darnovsky; Donna Dickenson; Hille Haker; Katie Hasson; Leah Lowthorp; George J Annas; Catherine Bourgain; Katherine Drabiak; Sigrid Graumann; Katrin Grüber; Matthias Kaiser; David King; Regine Kollek; Calum MacKellar; Jing-Bao Nie; Osagie K Obasogie; Mirriam Tyebally Fang; Gabriele Werner-Felmayer; Jana Zuscinova
Journal:  Trends Biotechnol       Date:  2020-01-31       Impact factor: 19.536

7.  Prospects for genetic intervention in man.

Authors:  B D Davis
Journal:  Science       Date:  1970-12-18       Impact factor: 47.728

8.  Is there a logical slippery slope from voluntary to nonvoluntary euthanasia?

Authors:  David Albert Jones
Journal:  Kennedy Inst Ethics J       Date:  2011-12

Review 9.  Human gene therapy: ethics and public policy.

Authors:  L Walters
Journal:  Hum Gene Ther       Date:  1991       Impact factor: 5.695

10.  The ethics of human gene therapy.

Authors:  L Walters
Journal:  Nature       Date:  1986 Mar 20-26       Impact factor: 49.962

View more
  1 in total

1.  Life 2.0-A CRISPR path to a sustainable planet.

Authors:  Dana Carroll; Barbara J Meyer
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-01       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.